Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
EMTRICITABINA/TENOFOVIR DISOPROXIL MYLAN 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Tablet
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- EMTRICITABINA — 200 mg
- TENOFOVIR DISOPROXILO MALEATO — 245 mg
- Pharmaceutical form Home Med Cabinet grouping
- Tablet
- Availability in Spain
- 1 of 2 packs marketed
Packs
EMTRICITABINA/TENOFOVIR DISOPROXIL MYLAN 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos (alu/alu)
30 pcs
National code
Marketed715025Strength of this pack 200 mg
EMTRICITABINA/TENOFOVIR DISOPROXIL MYLAN 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos (OPA/papel aluminio/PVC)
30 pcs
National code
Not marketed758141Strength of this pack 200 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 1161133004Official data
- Marketing authorisation holder
- MYLAN PHARMACEUTICALS LIMITEDOfficial data
- Authorised
- Feb 24, 2017Official data
- Authority form code
- 42Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.